Application of transcutaneous electrical acupoint stimulation under consciousness index monitoring in painless gastroscopy

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100049333

Enrollment

Unknown

Registered

2021-07-30

Start date

2021-08-01

Completion date

Unknown

Last updated

2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stomach trouble

Interventions

Observe group 1:Intravenous injection sufentanil, propofol, etomidate

Observe group 2:TEAS and intravenous injection sufentanil, propofol, etomidate

Control group:Intravenous injection saline, propofol, etomidate

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Older than 18; 2.ASA grade I-II; 3.Scheduled painless gastroscopy; 4.BMI 19-29kg/m^2; 5.Sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1.Patients are known to be allergic to the drugs used in this study or to the electrode tablets; 2.Long term opioid use, history of chronic pain, drug addiction or alcohol abuse, and 48 hours prior to surgery; 3.Severe hypertension, severe liver, kidney, and blood system diseases; 4.Pregnant or lactating women; 5.Poor compliance and inability to cooperate.

Design outcomes

Primary

Measure	Time frame
Mean arterial pressure;Heart rate;Oxyhemoglobin saturation;Injection pain;Choking cough;Body movement;	—

Secondary

Measure	Time frame
Check time;Wake-up time;Nausea, vomiting;Sedation score;	—

Countries

China

Contacts

Public ContactGao Yifan

Chinese People's Armed Police Characteristic Medical Center

gaoyifan007@sina.com+86 18502637082

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026